BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18034599)

  • 1. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords.
    Swords R
    Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Joseph Brandwein.
    Brandwein J
    Drugs; 2007; 67(17):2655. PubMed ID: 18034600
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Barbara Wassmann.
    Wassmann B
    Drugs; 2007; 67(17):2656. PubMed ID: 18034598
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ottmann OG; Wassmann B
    Hematology Am Soc Hematol Educ Program; 2005; ():118-22. PubMed ID: 16304368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.
    Tiribelli M; Sperotto A; Candoni A; Simeone E; Buttignol S; Fanin R
    Leuk Res; 2009 Jan; 33(1):174-7. PubMed ID: 18471874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ishii Y; Shoji N; Kimura Y; Ohyashiki K
    Intern Med; 2006; 45(5):339-40. PubMed ID: 16596010
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.
    Sanchez-Gonzalez B; Pascual-Ramirez JC; Fernandez-Abellan P; Belinchon-Romero I; Rivas C; Vegara-Aguilera G
    Blood; 2003 Mar; 101(6):2446. PubMed ID: 12609964
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
    Fielding AK; Rowe JM; Richards SM; Buck G; Moorman AV; Durrant IJ; Marks DI; McMillan AK; Litzow MR; Lazarus HM; Foroni L; Dewald G; Franklin IM; Luger SM; Paietta E; Wiernik PH; Tallman MS; Goldstone AH
    Blood; 2009 May; 113(19):4489-96. PubMed ID: 19244158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
    Savani BN; Srinivasan R; Espinoza-Delgado I; Dorrance C; Takahashi Y; Igarashi T; Rezvani K; Lundqvist A; Barrett AJ; Childs RW
    Lancet Oncol; 2005 Oct; 6(10):809-12. PubMed ID: 16198987
    [No Abstract]   [Full Text] [Related]  

  • 10. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib for relapsed BCR/ABL positive leukemias.
    Ottmann OG; Wassmann B; Hoelzer D
    Ann Hematol; 2002; 81 Suppl 2():S36-7. PubMed ID: 12611069
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
    Tachibana T; Numata A; Tanaka M; Motohashi K; Fujisawa S; Fujita H; Sakai R; Tomita N; Maruta A; Ishigatsubo Y; Kanamori H
    Leuk Lymphoma; 2011 Jul; 52(7):1376-9. PubMed ID: 21438838
    [No Abstract]   [Full Text] [Related]  

  • 13. Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Cross SA; Lyseng-Williamson KA
    Drugs; 2007; 67(17):2645-54. PubMed ID: 18034597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
    Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.
    Kovacsovics T; Maziarz RT
    Curr Oncol Rep; 2006 Sep; 8(5):343-51. PubMed ID: 16901395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.
    De Vita S; De Matteis S; Laurenti L; Chiusolo P; Sorà F; Piccirillo N; Reddiconto G; Fiorini A; Leone G; Sica S
    Ann Oncol; 2006 Apr; 17(4):720-1. PubMed ID: 16263757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Zhang FH; Ling YW; Zhai X; Zhang Y; Huang F; Fan ZP; Zhou HS; Jiang QL; Sun J; Liu QF
    Hematology; 2013 May; 18(3):151-7. PubMed ID: 23394269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial.
    Ribera JM; Oriol A; González M; Vidriales B; Brunet S; Esteve J; Del Potro E; Rivas C; Moreno MJ; Tormo M; Martín-Reina V; Sarrá J; Parody R; de Oteyza JP; Bureo E; Bernal MT; ;
    Haematologica; 2010 Jan; 95(1):87-95. PubMed ID: 19797728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Carpiuc KT; Stephens JM; Botteman MF; Feng W; Hay JW
    Expert Opin Pharmacother; 2007 Nov; 8(16):2775-87. PubMed ID: 17956198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.